Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?

Journal Article Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect? Get access Daniela Zurkan, Daniela Zurkan Department of Cardiology, Deutsches Herzzentrum der Charité, Angiology and Intensive Care Medicine, Augustenburger Platz 1, D-13353 Berlin, GermanyCharité—Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, GermanyDZHK (German Centre for Cardiovascular Research), Partner site Berlin, Berlin, Germany https://orcid.org/0009-0000-1016-439X Search for other works by this author on: Oxford Academic PubMed Google Scholar Bertram Pitt, Bertram Pitt University of Michigan School of Medicine, Ann Arbor, MI, USA https://orcid.org/0000-0001-5880-275X Search for other works by this author on: Oxford Academic PubMed Google Scholar Frank Edelmann Frank Edelmann Department of Cardiology, Deutsches Herzzentrum der Charité, Angiology and Intensive Care Medicine, Augustenburger Platz 1, D-13353 Berlin, GermanyCharité—Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, GermanyDZHK (German Centre for Cardiovascular Research), Partner site Berlin, Berlin, Germany Corresponding author. Tel: +49 30 450653731, Fax: +49 30 4507553731, Email: frank.edelmann@dhzc-charite.de https://orcid.org/0000-0003-4401-5936 Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, Volume 45, Issue 10, 7 March 2024, Pages 775–777, https://doi.org/10.1093/eurheartj/ehae040 Published: 06 February 2024